Indivior Past Earnings Performance

Past criteria checks 0/6

Indivior's earnings have been declining at an average annual rate of -16.1%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 11.5% per year.

Key information

-16.1%

Earnings growth rate

-16.7%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate11.5%
Return on equityn/a
Net Margin-0.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Indivior: This Value Stock Has Over 100% Upside Potential If Market Share Stabilizes In 2025

Oct 13

Indivior: Management Takes Advantage Of Sell-Off As Board Approves Another $100m Buyback

Jul 26

Revenue & Expenses Breakdown

How Indivior makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:INDV Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,182-3572105
30 Jun 241,147-141750101
31 Mar 241,1245571107
31 Dec 231,0932543106
30 Sep 231,042-235526106
30 Jun 231,002-59488108
31 Mar 23947-5046991
31 Dec 22901-5346172
30 Sep 2288216646062
30 Jun 2283815246053
31 Mar 2281816644651
31 Dec 2179120542552
30 Sep 2175315640247
30 Jun 2172513938443
31 Mar 216749539139
31 Dec 20647-14842740
30 Sep 20595-19042843
30 Jun 20634-15243947
31 Mar 20700-9542751
31 Dec 1978513439053
30 Sep 1988921338653
30 Jun 1993525440458
31 Mar 1998824844963
31 Dec 181,00527547867
30 Sep 181,03310672272
30 Jun 181,0646776079
31 Mar 181,0837173080
31 Dec 171,0935870789
30 Sep 171,08728148299
30 Jun 171,08081434104
31 Mar 171,06565444113
31 Dec 161,05835456119
30 Sep 161,047-6443128
30 Jun 161,028191440137
31 Mar 161,021201423143
31 Dec 151,014228408132
30 Sep 151,037268388143
30 Jun 151,058314368131
31 Mar 151,085361332119
31 Dec 141,115403343115
30 Sep 141,14744332599
31 Dec 131,21648934176

Quality Earnings: INDV is currently unprofitable.

Growing Profit Margin: INDV is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: INDV is unprofitable, and losses have increased over the past 5 years at a rate of 16.1% per year.

Accelerating Growth: Unable to compare INDV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: INDV is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).


Return on Equity

High ROE: INDV's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 01:23
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Indivior PLC is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Graham Glyn ParryBofA Global Research
Brian WhiteCantor Fitzgerald Europe
Chase KnickerbockerCraig-Hallum Capital Group LLC